Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IRD Opus Genetics Inc.
- Stocks
- Healthcare
- NASDAQ: IRD
Price (delayed)
$0.9958
Market cap
$45.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.15
Enterprise value
$14.97M
Highlights
The revenue is down by 42% year-on-year but it is up by 31% since the previous quarter
IRD's gross profit is down by 42% YoY but it is up by 31% QoQ
The company's net income has shrunk by 112% QoQ
The company's EPS has shrunk by 97% QoQ
Key stats
What are the main financial stats of IRD
Market
Valuations
Earnings
Shares outstanding
45.48M
Market cap
$45.29M
Enterprise value
$14.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.68
Price to sales (P/S)
2.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
Revenue
$10.99M
Gross profit
$10.99M
Operating income
-$62.07M
Net income
-$57.53M
EBIT
-$57.53M
EBITDA
-$57.52M
Free cash flow
-$25.58M
Per share
Balance sheet
Liquidity
EPS
-$2.15
EPS diluted
-$2.15
Free cash flow per share
-$0.96
Book value per share
$0.21
Revenue per share
$0.41
TBVPS
$1.38
Total assets
$36.86M
Total liabilities
$11.3M
Debt
$0
Equity
$6.72M
Working capital
$25.32M
Debt to equity
0
Current ratio
3.24
Quick ratio
3.2
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
-523.3%
Gross margin
100%
Net margin
-523.4%
Operating margin
-564.7%
Return on assets
-132.3%
Return on equity
-180.2%
Return on invested capital
N/A
Return on capital employed
-225%
Return on sales
-523.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRD stock price
How has the Opus Genetics stock price performed over time
Intraday
-2.37%
1 week
6.16%
1 month
33%
1 year
-45.58%
YTD
-16.32%
QTD
1.43%
Financial performance
How have Opus Genetics's revenue and profit performed over time
Revenue
$10.99M
Gross profit
$10.99M
Operating income
-$62.07M
Net income
-$57.53M
Gross margin
100%
Net margin
-523.4%
The company's net income has shrunk by 112% QoQ
The operating income has plunged by 111% from the previous quarter
Opus Genetics's net margin has shrunk by 61% QoQ
The operating margin has dropped by 61% since the previous quarter
Price vs fundamentals
How does IRD's price correlate with its fundamentals
Growth
What is Opus Genetics's growth rate over time
Valuation
What is Opus Genetics stock price valuation
P/E
N/A
P/B
4.68
P/S
2.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
The company's EPS has shrunk by 97% QoQ
The P/B is 113% above the last 4 quarters average of 2.2 and 80% above the 5-year quarterly average of 2.6
Opus Genetics's equity has shrunk by 87% YoY and by 80% QoQ
The revenue is down by 42% year-on-year but it is up by 31% since the previous quarter
IRD's P/S is 19% below its last 4 quarters average of 3.0
Efficiency
How efficient is Opus Genetics business performance
Opus Genetics's return on equity has shrunk by 183% QoQ
IRD's ROA has plunged by 133% from the previous quarter
The company's return on sales has shrunk by 61% QoQ
Dividends
What is IRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRD.
Financial health
How did Opus Genetics financials performed over time
The total liabilities has surged by 179% year-on-year and by 85% since the previous quarter
The current ratio has dropped by 76% year-on-year and by 51% since the previous quarter
Opus Genetics's debt is 100% lower than its equity
Opus Genetics's equity has shrunk by 87% YoY and by 80% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.